According to a previous paper, in PSP and PD, distinct subcortical 18F-AV-1451 binding patterns have been described, reflecting subcortical tau pathology in PSP and reduced nigral neuromelanin in PD. This evidence concerns the gene MAPT and Parkinson disease.